Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director departure
INFINITY PHARMACEUTICALS, INC. (INFI) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2022 SC 13G Polar Capital Holdings Plc reports a 5.6% stake in Infinity Pharmaceuticals, Inc.
02/10/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/04/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/17/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/19/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/26/2021 SC 13G EcoR1 Capital, LLC reports a 6.8% stake in Infinity Pharmaceuticals, Inc.
09/18/2020 SC 13G Opaleye Management Inc. reports a 5.1% stake in INFINITY PHARMACEUTICALS, INC.
02/13/2018 SC 13G FMR LLC reports a 7.1% stake in INFINITY PHARMACEUTICALS INC
02/09/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
06/24/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
04/16/2013 SC 13G SAC Capital Advisors LP reports a 5% stake in INFINITY PHARMACEUTICALS, INC.
03/30/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/14/2012 SC 13G INFINITY PHARMACEUTICALS, INC. reports a 6.3% stake in INFINITY PHARMACEUTICALS INC
02/09/2011 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
01/29/2010 SC 13G ADVENT VENTURE PARTNERS LLP reports a 4.3% stake in Infinity Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy